Pinnacle Financial Partners (Tennessee)’s Quest Diagnostics DGX Stock Holding History

Pinnacle Financial Partners (Tennessee)’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$276K	Sell	1,449 -82	-5%	-$14.6K	0.01%	415
2025 Q2	$275K	Buy	1,531 +188	+14%	+$32.7K	0.01%	403
2025 Q1	$227K	Buy	1,343 +10	+0.8%	+$1.64K	﹤0.01%	426
2024 Q4	$201K	Sell	1,333 -11	-0.8%	-$1.71K	﹤0.01%	436
2024 Q3	$209K	Buy	+1,344	New	+$201K	﹤0.01%	432
2022 Q1	–	Sell	-1,175	Closed	-$203K	–	446
2021 Q4	$203K	Buy	+1,175	New	+$179K	0.01%	382

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Pinnacle Financial Partners (Tennessee)'s DGX Position: Q3 2025 in Review

Pinnacle Financial Partners (Tennessee) reduced its Quest Diagnostics (DGX) stake by 5.4% in Q3 2025, selling an estimated $14.6K and leaving 1,449 shares worth $276K. The position accounts for 0.01% of the portfolio, ranked #415.

Pinnacle Financial Partners (Tennessee) first reported a position in DGX in Q4 2021 and has held it in 6 quarters since. 1,005 funds tracked by Wall St. Rank hold DGX as of Q3 2025.

Pinnacle Financial Partners (Tennessee) held 1,449 shares of Quest Diagnostics worth $276K as of Q3 2025.
Pinnacle Financial Partners (Tennessee) sold 82 Quest Diagnostics shares in Q3 2025, an estimated $14.6K.
Quest Diagnostics made up 0.01% of Pinnacle Financial Partners (Tennessee)'s portfolio in Q3 2025, its #415 holding.
Pinnacle Financial Partners (Tennessee) first reported a position in Quest Diagnostics in Q4 2021 and has held it in 6 quarters since.
1,005 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2025.

Based on Pinnacle Financial Partners (Tennessee)'s 13F filing for Q3 2025, filed 28 Oct 2025.